JP2002047199A - Method for enhancing efficacy of crude drug - Google Patents

Method for enhancing efficacy of crude drug

Info

Publication number
JP2002047199A
JP2002047199A JP2000227337A JP2000227337A JP2002047199A JP 2002047199 A JP2002047199 A JP 2002047199A JP 2000227337 A JP2000227337 A JP 2000227337A JP 2000227337 A JP2000227337 A JP 2000227337A JP 2002047199 A JP2002047199 A JP 2002047199A
Authority
JP
Japan
Prior art keywords
crude drug
treatment
present
electromagnetic wave
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000227337A
Other languages
Japanese (ja)
Inventor
Michishi Tani
美智士 谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000227337A priority Critical patent/JP2002047199A/en
Publication of JP2002047199A publication Critical patent/JP2002047199A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new crude drug therapeutic agent utilizing vital energy in crude drug therapy. SOLUTION: This method for enhancing the efficacy of the crude drug is characterized by subjecting a crude drug extract liquid to treatment with electromagnetic waves at 50-250 MHz and 100-300 W for 30 s to 10 min, energization at 30-100 kHz and 3-10 V for 30-60 s, magnetic treatment at 10-3,000 Gausses and treatment with ultrasonic waves at 100-300 W for 3-10 min alone or in combination simultaneously.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は生薬の効力増強方法
に関する。
TECHNICAL FIELD The present invention relates to a method for enhancing the efficacy of a crude drug.

【0002】[0002]

【従来の技術】生薬を利用する東洋医学は長い歴史と実
績を有するが、癌、エイズ、膠原病などの難病の治療に
はさらなる改善が求められている。
2. Description of the Related Art Oriental medicine using crude drugs has a long history and achievements, but further improvement is required for treatment of intractable diseases such as cancer, AIDS and collagen disease.

【0003】[0003]

【発明が解決しようとする課題】上記のごとき従来技術
の現状に鑑み、本発明は、東洋医学において使用される
生薬の効力の増強方法を提供しようとするものである。
In view of the state of the art as described above, the present invention seeks to provide a method for enhancing the efficacy of crude drugs used in Oriental medicine.

【0004】[0004]

【課題を解決するための手段】上記の課題を解決すべく
種々研究した結果、本発明者は、東洋医学において
「気」を応用すること、具体的には生薬等に「気を入れ
る」又は「気を発生させる」ことにより、上記の課題を
解決した。より具体的には、本発明者は、生薬に所定の
電磁波をかけることにより上記の課題を解決することが
できることを始めて見出し、本発明を完成した。従って
本発明は、生薬抽出液に50〜250MHz の電磁波を3
0秒間〜30分間かけることを特徴とする生薬の効果増
強方法を提供する。
As a result of various studies to solve the above-mentioned problems, the present inventor has applied "ki" in oriental medicine, specifically, "careful" or The above problem was solved by "generating the energy". More specifically, the present inventor has first found that the above problem can be solved by applying a predetermined electromagnetic wave to a crude drug, and has completed the present invention. Therefore, the present invention applies three electromagnetic waves of 50 to 250 MHz to the crude drug extract.
Provided is a method for enhancing the effect of a crude drug, which is performed for 0 second to 30 minutes.

【0005】[0005]

【発明の実施の形態】本発明の方法は、種々の生薬に適
用することができ、特に限定されないが、例えば、独活
寄生物、消風散、天寿散のごとき生薬に適用することが
できる。本発明の方法により処理した生薬により治療で
きる病気は特に限定されないが、例えば難病といわれ
る、各種の癌、エイズ、膠原病、関節リウマチ等の治療
に効果がある。上記癌の種類としては、肺癌、乳癌、肝
癌、皮膚癌などが挙げられる。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The method of the present invention can be applied to various crude drugs, and is not particularly limited. For example, the method can be applied to crude drugs such as indigenous parasites, Kousan and Tenjusan. Diseases that can be treated with the crude drug treated by the method of the present invention are not particularly limited, but are effective for treating various cancers, such as intractable diseases, AIDS, collagen disease, rheumatoid arthritis, and the like. Examples of the types of cancer include lung cancer, breast cancer, liver cancer, and skin cancer.

【0006】本発明においては、上記のごとき生薬の抽
出液を処理する。抽出液は、生薬を常法に従って、水や
熱水で処理することにより得られ、その具体的な方法
は、各生薬や用途ごとに当業界において確立されてい
る。抽出液は、50〜250MHzの電磁波を30秒間〜
30分間適用することにより得られる。電磁波の強度は
100〜300Wが好ましい。電磁波の発生器として
は、常用の発生器等を使用することができる。
In the present invention, a crude drug extract as described above is treated. The extract is obtained by treating a crude drug with water or hot water according to a conventional method, and a specific method has been established in the art for each crude drug and application. The extract is irradiated with electromagnetic waves of 50 to 250 MHz for 30 seconds to
Obtained by applying for 30 minutes. The intensity of the electromagnetic wave is preferably from 100 to 300 W. As the generator of the electromagnetic wave, a common generator or the like can be used.

【0007】本発明の好ましい態様においては、電磁波
による処理に通電、超音波、又は磁気を加えて有効性を
高める。磁気としては、周期的に変化しない磁気を適用
する。磁気の強度は1000〜3000ガウスが好まし
い。通電は30kHz 〜100kHz 、3〜10V、30〜
60秒、超音波は100〜300W、3〜10分を追加
するとさらに望ましい。電磁波にこれ等の複類のものを
適用する場合にはその順序はいずれであってもよい。電
磁波、超音波又は磁気による処理は、例えば生薬抽出液
を例えば磁気を通す合成樹脂性チューブを通しながら、
その外部から電磁波又は磁気を適用することにより行う
ことができる。さらに電磁波に代えて、物理的にほぼ同
じ作用を持つと考えられている光刺激を与えてもよい。
[0007] In a preferred embodiment of the present invention, the effectiveness is enhanced by applying electricity, ultrasonic waves or magnetism to the treatment with electromagnetic waves. As the magnetism, magnetism that does not change periodically is applied. The magnetic strength is preferably from 1,000 to 3,000 Gauss. Energization is 30kHz ~ 100kHz, 3 ~ 10V, 30 ~
More preferably, the ultrasonic wave is added at 100 to 300 W for 3 to 10 minutes for 60 seconds. When these two types are applied to the electromagnetic wave, the order may be any order. The treatment by electromagnetic waves, ultrasonic waves or magnetism, for example, while passing the herbal extract through, for example, a synthetic resin tube that passes magnetism,
It can be performed by applying electromagnetic waves or magnetism from outside. Further, instead of the electromagnetic wave, a light stimulus which is considered to have substantially the same physical effect may be applied.

【0008】[0008]

【実施例】次に、本発明を実施例によりさらに具体的に
説明する。実施例1. 生薬(長白散)1日量28gを100℃の水
500mLにより抽出し、薬剤抽出液を得た。抽出液を、
電磁波処理しない場合にはそのまま投与し、電磁波処理
するものは、200Wの強度の117MHz の電磁波を約
1分間適用した。患者の免疫力を、免疫リンパ球(NK
細胞などのT細胞)の数とバランスにより測定するか、
東洋医学的に脈診による「正気」の強さにより測定し
た。
Next, the present invention will be described more specifically with reference to examples. Embodiment 1 FIG. A daily amount of crude drug (Changakusan), 28 g, was extracted with 500 mL of water at 100 ° C. to obtain a drug extract. Extract liquid
In the case where no electromagnetic wave treatment was performed, administration was carried out as it was, and in the case of electromagnetic wave treatment, a 117 MHz electromagnetic wave having an intensity of 200 W was applied for about 1 minute. The patient's immunity is measured by using immune lymphocytes (NK
Or the number and balance of T cells
In Oriental medicine, it was measured by the intensity of "sanity" by pulse diagnosis.

【0009】53歳の男性肺癌患者に、電磁波処理して
ない生薬抽出液を、投与量28gで2ヶ月間投与したが
免疫力には著明な上昇はなかった。続いて、電磁波処理
した生薬抽出液を3ヶ月間投与したところ、免疫力は経
時的に上昇した。この結果を図1に示す。電磁波処理し
ない生薬抽出液の投与から、電磁波処理した生薬抽出液
の投与に変えた時点から免疫力が上昇に転じたことか
ら、生薬抽出液に対する電磁波処理の効果が確信され
た。
A crude drug extract which had not been subjected to electromagnetic wave treatment was administered to a 53-year-old male lung cancer patient at a dose of 28 g for 2 months, but there was no marked increase in immunity. Subsequently, when the crude drug extract subjected to the electromagnetic wave treatment was administered for 3 months, the immunity increased with time. The result is shown in FIG. Immunity started to increase from the point where the administration of the crude drug extract without electromagnetic wave treatment was changed to the administration of the crude drug extract treated with electromagnetic wave, confirming the effect of the electromagnetic wave treatment on the crude drug extract.

【0010】実施例2.生薬(天寿散(No.7))2
8gを100℃の水300mLにより抽出し、電磁波処理
しない場合にはそのまま投与し、電磁波処理する場合に
は200Wの強度の117MHz の電磁波を約1分間適用
した。患者の免疫力は実施例1のようにして測定した。
Embodiment 2 FIG . Crude drug (Tenjusan (No. 7)) 2
Eight grams were extracted with 300 mL of water at 100 ° C., and administered without treatment with electromagnetic waves, and applied with 117 W electromagnetic waves of 200 W intensity for about 1 minute when treated with electromagnetic waves. The patient's immunity was measured as in Example 1.

【0011】52歳の男性の肺癌患者に、電磁波処理し
た生薬抽出液を、上記投与量で2ヶ月間投与したとこ
ろ、免疫力が経時的に上昇した。その後、投与を、電磁
波処理していない生薬抽出液の投与に切り替えたとこ
ろ、免疫力は経時的に低下した。この結果を図2に示
す。この結果から、担癌患者における免疫力の向上のた
めに、生薬抽出液の電磁波処理が有効であることが明ら
かである。
When a 52-year-old male lung cancer patient was treated with the above-mentioned dose of the herb extract treated with electromagnetic waves for 2 months, the immunity increased with time. Thereafter, when the administration was switched to administration of a crude drug extract that had not been subjected to electromagnetic wave treatment, the immunity decreased over time. The result is shown in FIG. From these results, it is clear that electromagnetic wave treatment of the crude drug extract is effective for improving immunity in cancer-bearing patients.

【0012】症例1.(71歳の女性) 1979年10月、右乳房全摘手術(T2n1 0 =St
ageII)。術後、放射線治療の他、MMC及び5FU
により化学療法を1983年まで行った。以後再発所見
全く無く、全身状態良好のため経過観察とした。
Case 1. (71-year-old woman) Right mastectomy (T 2n1 M 0 = St, October 1979)
age II). Postoperatively, radiation therapy, MMC and 5FU
Provided chemotherapy until 1983. Thereafter, no recurrence was found, and the patient was followed up because his general condition was good.

【0013】1988年3月、全身倦怠、呼吸困難等で
再来。肺、肝臓に多数の転移再発が認められた。直ちに
抗癌剤治療を開始したが、副作用が著しく、腫瘍に対し
て有効性を認められないため、化学治療を中止し、長白
散及びAstol BWを主力とする中医的治療に変更
した。この時点での腫瘍マーカー値はCEA(71.
7)、CA15−3(6110)であった。なお、CE
Aは広く担癌患者で血中測定値が2.5以上になり、癌
細胞が作り出す特殊な蛋白体であり、CA15−3は乳
癌に特有の腫瘍マーカーで正常値は35以下である。
In March 1988, he returned due to general malaise and dyspnea. Numerous metastatic recurrences were found in the lungs and liver. The chemotherapy treatment was started immediately, but the side effects were remarkable and the efficacy against the tumor was not recognized. Therefore, the chemotherapy was discontinued, and the treatment was changed to a Chinese medicine treatment mainly comprising Changhakusan and Astol BW. The tumor marker value at this point was CEA (71.
7), CA15-3 (6110). In addition, CE
A is a special protein produced by cancer cells with a blood measurement value of 2.5 or more in cancer-bearing patients. CA15-3 is a tumor marker specific to breast cancer and has a normal value of 35 or less.

【0014】なお長白散は、免疫力を上昇せしめ、その
機能を十分に発揮させるための生薬複合方剤で、猪苓、
茯苓、海藻、甘草などが主剤である。Astolは植物
エキス剤で、免疫力の改善や細胞の特性を計ることが出
来る。いずれも、施行条件は電磁波(200W、117
MHz )、磁気(1800ガウス)、超音波(130W、
5分間)とし電磁波及び磁気はポリウレタンチューブを
通して作用させた。
Chohaku-san is a herbal medicine complex for increasing immunity and fully exerting its function.
Bukuryo, seaweed and licorice are the main agents. Astol is a plant extract that can improve immunity and measure cell properties. In each case, the enforcement conditions were electromagnetic waves (200 W, 117
MHz), magnetic (1800 gauss), ultrasonic (130 W,
5 minutes), and electromagnetic waves and magnetism were applied through a polyurethane tube.

【0015】1988年4月、上記症状が改善し、QO
L(Quality of Life;生活の質)が著
しく改善し、間もなく退院した。1989年1月、CT
上、転移像が全く消失し、自覚症状もなかった。199
0年5月、再発の所見なく、CT上の異常もなかった。
1990年9月、腫瘍マーカー値CEA(3.5)、C
A15−3(32.5)であった。
[0015] In April 1988, the above symptoms improved,
L (Quality of Life; quality of life) improved significantly, and she was discharged soon. January 1989, CT
Above, the metastatic image completely disappeared and there was no subjective symptom. 199
In May 2000, there was no recurrence and no CT abnormalities.
September 1990, tumor marker values CEA (3.5), C
A15-3 (32.5).

【0016】図3に治療経過を示す。図4は、再入院時
の肝のレントゲンCT像を示す。多数の円形に濃くなっ
ている部分が癌転移像である。図4は、生薬(長白散+
Astol)治療開始から3ヶ月後の肝のCT像であ
る。癌転移が次第に融解したように見える。図7は、生
薬治療後6ヶ月の肝CT像である。癌転移の腫瘍像は次
第に消失しつつある。図7は、生薬治療開始1年後のC
T像である。転移癌はほぼ完全に消失している。図7
は、生薬治療前の肺のCT像であり、小円形状の癌陰影
が多数認められる。図8は、生薬治療開始6ヶ月後の肺
のCT像であり、小円形陰影はほぼ消失している。
FIG. 3 shows the course of treatment. FIG. 4 shows an X-ray CT image of the liver at the time of readmission. A large number of circularly dark portions are cancer metastasis images. Fig. 4 shows the crude drug (Changakusan +
(Astol) CT image of liver 3 months after the start of treatment. The metastases appear to have gradually melted. FIG. 7 is a liver CT image 6 months after the crude drug treatment. The tumor image of cancer metastasis is gradually disappearing. Fig. 7 shows C one year after starting crude drug treatment.
It is a T image. Metastatic cancer has almost completely disappeared. FIG.
Is a CT image of the lung before the herbal medicine treatment, and many small circular cancer shadows are observed. FIG. 8 is a CT image of the lung 6 months after the start of the crude drug treatment, and the small circular shadow has almost disappeared.

【0017】症例2.(68歳の女性) 1989年4月に左乳房全摘手術を受けた後、種々の治
療を受けたが、治癒−再発を繰りかえし、1996年1
月には、骨シンチグラフにて頚椎、胸椎、腰椎、左右肋
骨、骨盤などに多数の転移巣が認められた(図9)。1
996年2〜3月には、食欲不振著しく、殆ど摂食不能
となり、腫瘍マーカーCA15−3が4,000近くに
上昇した。
Case 2. (68-year-old woman) After undergoing a left mastectomy in April 1989, she received various treatments.
On the moon, a number of metastatic lesions were found on the cervical vertebra, thoracic vertebra, lumbar vertebra, left and right ribs, pelvis, etc. on a bone scintigraph (FIG. 9). 1
From February to March 996, anorexia was remarkable and almost inedible, and the tumor marker CA15-3 rose to nearly 4,000.

【0018】1996年5月に、長白散及びAstol
BW(症例1と同様に処理したもの)により東洋医学
的治療を開始し、痛みが徐々に軽くなり、少しづつ食欲
も回復し、腫瘍マーカーも少しづつ改善した。1996
年7月、体重が増え、食欲も殆ど回復し、腫瘍マーカー
も引き続き低下した。1996年9月には、骨シンチグ
ラフにおいて転移巣はほぼ消失した(図10)。199
6年10月、腫瘍マーカーAC15−3は40.2に回
復し、ほぼ日常生活が可能となった。
In May 1996, Changhakusan and Astol
Oriental medical treatment was started with BW (treated in the same manner as in case 1), the pain gradually decreased, the appetite gradually recovered, and the tumor markers gradually improved. 1996
In July, he gained weight, his appetite almost recovered, and his tumor markers continued to decline. In September 1996, metastatic lesions almost disappeared in bone scintigraphy (FIG. 10). 199
In October 2006, the tumor marker AC15-3 recovered to 40.2, and almost daily life became possible.

【0019】[0019]

【発明の効果】以上の通り、本発明に従って、生薬を電
磁波処理、超音波、通電及び磁気処理すれば、生薬の薬
理効果は、顕著に改善される。
As described above, the pharmacological effect of a crude drug is remarkably improved by subjecting the crude drug to electromagnetic wave treatment, ultrasonic wave, electric current and magnetic treatment according to the present invention.

【図面の簡単な説明】[Brief description of the drawings]

【図1】図1は、本発明の電磁波処理した生薬の投与に
より、電磁波処理しない生薬の投与に比べて、免疫力の
上昇が顕著であることを示すグラフである。
FIG. 1 is a graph showing that administration of a crude drug treated with electromagnetic waves of the present invention significantly increases immunity compared to administration of a crude drug not treated with electromagnetic waves.

【図2】図2は、本発明の電磁波処理した生薬の投与に
より上昇した免疫力が、処理しない生薬の投与により下
降することを示すグラフである。
FIG. 2 is a graph showing that the increased immunity due to the administration of a crude drug treated with electromagnetic waves of the present invention decreases with the administration of an untreated crude drug.

【図3】図3は、本発明の処理を行った生薬により乳癌
の肝、肺転移の治療を行った場合の治療の経過を示すグ
ラフの1例である。
FIG. 3 is an example of a graph showing the progress of treatment in the case of treating liver and lung metastases of breast cancer with a crude drug treated according to the present invention.

【図4】図4は、本発明の治療開始時の肝臓のCT像を
示す写真であり、生物の形態を示す図面代用写真であ
る。
FIG. 4 is a photograph showing a CT image of the liver at the start of the treatment according to the present invention, and is a drawing substitute photograph showing the form of an organism.

【図5】図5は、本発明の生薬治療開始3ヶ月後の肝臓
のCT像を示す写真であり、生物の形態を示す図面代用
写真である。
FIG. 5 is a photograph showing a CT image of the liver three months after the start of the herbal medicine treatment of the present invention, and is a drawing substitute photograph showing the form of an organism.

【図6】図6は、本発明の生薬治療開始6ヶ月後の肝臓
のCT像を示す写真であり、生物の形態を示す図面代用
写真である。
FIG. 6 is a photograph showing a CT image of a liver 6 months after the start of the herbal medicine treatment of the present invention, and is a drawing substitute photograph showing the form of an organism.

【図7】図7は、本発明の生薬治療開始1年後の肝臓の
CT像を示す写真であり、生物の形態を示す図面代用写
真である。
FIG. 7 is a photograph showing a CT image of the liver one year after the start of the herbal medicine treatment of the present invention, and is a drawing substitute photograph showing the form of an organism.

【図8】図8は、本発明の治療開始時の肺のCT像を示
す写真であり、生物の形態を示す図面代用写真である。
FIG. 8 is a photograph showing a CT image of the lung at the start of the treatment according to the present invention, and is a drawing substitute photograph showing the form of an organism.

【図9】図9は、本発明の生薬による治療開始12ヶ月
後の肺のCT像を示す写真であり、生物の形態を示す図
面代用写真である。
FIG. 9 is a photograph showing a CT image of the lung 12 months after the start of treatment with the crude drug of the present invention, and is a drawing substitute photograph showing the form of an organism.

【図10】図10は、症例2において、1996年1月
(本発明の生薬による治療開始時)における骨シンチグ
ラフであり、生物の形態を示す図面代用写真である。
FIG. 10 is a bone scintigraph of Case 2, taken in January 1996 (at the start of treatment with the crude drug of the present invention), and is a photograph substituted for a drawing, showing the morphology of an organism.

【図11】図11は、症例2において、1996年9月
における骨シンチグラフであり、生物の形態を示す図面
代用写真である。
FIG. 11 is a bone scintigraph in September 1996 in Case 2, which is a drawing-substituting photograph showing the form of an organism.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 生薬抽出液に50〜250MHz の電磁波
を30秒間〜30分間かけることを特徴とする、生薬の
効力増強方法。
1. A method for enhancing the efficacy of a crude drug, comprising applying an electromagnetic wave of 50 to 250 MHz to the crude drug extract for 30 seconds to 30 minutes.
【請求項2】 さらに、1000〜3000ガウスの磁
気をかけることを特徴とする、請求項1に記載の方法。
2. The method according to claim 1, further comprising applying a magnetic field of 1000 to 3000 Gauss.
【請求項3】 前記効力増強が、生薬が有する免疫増強
・調節作用の強化である、請求項1又は2に記載の方
法。
3. The method according to claim 1, wherein the potentiating effect is enhancing the immunopotentiating / modulating action of the crude drug.
JP2000227337A 2000-07-27 2000-07-27 Method for enhancing efficacy of crude drug Pending JP2002047199A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000227337A JP2002047199A (en) 2000-07-27 2000-07-27 Method for enhancing efficacy of crude drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000227337A JP2002047199A (en) 2000-07-27 2000-07-27 Method for enhancing efficacy of crude drug

Publications (1)

Publication Number Publication Date
JP2002047199A true JP2002047199A (en) 2002-02-12

Family

ID=18720806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000227337A Pending JP2002047199A (en) 2000-07-27 2000-07-27 Method for enhancing efficacy of crude drug

Country Status (1)

Country Link
JP (1) JP2002047199A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603563A1 (en) * 2003-02-28 2005-12-14 Morgan, Lee Roy, c/o Dekk-Tec Inc. Resonance modulator for diagnosis and therapy
JP2009525289A (en) * 2006-01-31 2009-07-09 パルスロース カンパニー Herbal extracts with immunomodulatory properties

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603563A1 (en) * 2003-02-28 2005-12-14 Morgan, Lee Roy, c/o Dekk-Tec Inc. Resonance modulator for diagnosis and therapy
EP1603563A4 (en) * 2003-02-28 2007-08-22 Morgan Lee R Resonance modulator for diagnosis and therapy
JP2009525289A (en) * 2006-01-31 2009-07-09 パルスロース カンパニー Herbal extracts with immunomodulatory properties

Similar Documents

Publication Publication Date Title
JP2003088329A (en) Analgesic health supplement
Park et al. Integrative tumor board: a case report and discussion from East-West Cancer Center
JP2002047199A (en) Method for enhancing efficacy of crude drug
Porile et al. Gastric adenocarcinoma presenting with soft tissue masses.
CN103830717B (en) A kind of Chinese medicine for the treatment of atrophic gastritis and preparation method thereof
CN104383244A (en) Traditional Chinese medicine composition for treating esophagus cancer and preparation method of traditional Chinese medicine composition
Zevallos et al. Epidural spinal cord compression from metastatic tumor
CN102335311A (en) Decoction for treating intestinal obstruction, and application thereof
CN102772617B (en) Medicine for treating disease of hyperosteogeny
CN109646558A (en) A kind of Chinese patent drug and preparation method thereof for treating lung cancer
US20040241259A1 (en) Herbal ointment and method for constipation treatment
RU2456030C1 (en) Method of treating osteoarthrosis with underlying hypertension
CN103977276A (en) Traditional Chinese medicine capsule used for treating radiocystitis
Tangjitjaroen Acupuncture for the treatment of spinal cord injuries
WO2019061862A1 (en) Shell nacre matrix protein, preparation method therefor, and use thereof
CN103877397B (en) A kind of medicine of radiotherapy injury of lung and preparation method
RU2564146C1 (en) Method of treating patients with calculi in lower one-third of ureters
Tsuei Recent developments in clinical acupuncture
WO2011094811A1 (en) Method of identifying a target area for delivery of a therapeutic operant and related methods of prophylaxis or treatment
RU2105577C1 (en) Method for treating the cases of hypomotor hypokinetic dyskinesia of biliary tract
Omura et al. Severe asthma with markedly increased asbestos of 2 types & TXB2, and markedly reduced acetylcholine, DHEA & drug uptake in parts of upper lungs, & similar abnormalities at respiratory & cardiac center of medulla oblongata: complete elimination of this asthma within 15 days using one optimal dose of astragalus & application of strong red light & EMF neutralizer on respiratory centers of abnormal medulla oblongata
CN106728819A (en) A kind of medicine and preparation method for treating chronic dermatitis
Shikhlyarova et al. Formation of the system of anti-stressor reactions as a non-specific basis for health and longevity
RU2121378C1 (en) Method for treating the cases of urolithiasis
CN104825628A (en) Chinese patent medicine for treating myasthenia gravis and asthenia of livers and kidneys and method for manufacturing Chinese patent medicine